Validation of 213Bi-α radioimmunotherapy for multiple myeloma

Clinical Cancer Research

Volumn 5, Issue 10 SUPPL., 1999, Pages

  Couturier, Olivier ^a   Faivre Chauvet, Alain ^a   Filippovich, Igor V ^a   Thédrez, Philippe ^a   Saï Maurel, Catherine ^a   Bardiès, Manuel ^a   Mishra, Anil K ^e   Gauvrit, Magali ^b   Blain, Guy ^b   Apostolidis, Christos ^d   Molinet, Roger ^e   Abbe, Jean Charles ^b   Bataille, Regis ^a   Wijdenes, John ^c   Chatal, Jean François ^a   Chérel, Michel ^a  

^a INSTITUT DE BIOLOGIE   (France)

^b SUBATECH   (France)

^c Diaclone   (France)

^d JOINT RESEARCH CENTRE   (Italy)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH 213; CHELATING AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BB 4; PENTETIC ACID DERIVATIVE; RADIOISOTOPE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG; BISMUTH;

APOPTOSIS; BONE MARROW PURGING; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MEGADOSE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IRRADIATION; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; ALPHA RADIATION; ARTICLE; CELL CULTURE; CELL SURVIVAL; HEMATOPOIETIC STEM CELL; ISOTOPE LABELING; METABOLISM; RADIATION EXPOSURE;

ALPHA PARTICLES; APOPTOSIS; BISMUTH; CELL SURVIVAL; HEMATOPOIETIC STEM CELLS; HUMANS; ISOTOPE LABELING; MULTIPLE MYELOMA; RADIOIMMUNOTHERAPY; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0032589762     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Attal, M., Harousseau, J.-L., Stoppa, A.-M., Sotto, J.-.I., Fuzibet, J.-G., Rossi, J.-F., Casassus, P., Maisoneuve, H., Facon, T., Ifrah, H., Payen, C., and Bataille, R. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N. Engl. J. Med., 335: 91-97, 1996.
2. Bataille, R., and Harousseau, J. L. Multiple myeloma. N. Engl. J. Med., 336: 1657-1664, 1997.
3. Wijdenes, J., Vooijs, W. C., Clément, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R.-X., Klein, B., and Dore, J.-M. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br. J. Haematol., 94: 318-323, 1996.
4. Luque, R., Brieva, J. A., Moreno, A., Manzanal, A., Escribano, L., Villarrubia, J., Velasco, J. L., Lopez, J. J., Cervero, C., Otero, M. J., Martinez, J., Bellas, C., and Roldan, E. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients - diagnostic and clinical implications. Clin. Exp. Immunol., 112: 410-418, 1998.
5. Pellat, D. C., Bataille, R., Robillard, N., Harousseau, J. L., Rapp, M. J., Juge, M. N., Wijdenes, J., and Amiot, M. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood, 84: 2597-2603, 1994.
6. Palacios, M. F., Perez, M. A., and Scolnik, M. P. B-B4 monoclonal antibody and identification of human bone marrow plasma cells. Br. J. Haematol., 96: 655-657, 1997.
7. Matsuoka, Y., Moore, G. E., Yagi, Y., and Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med., 725: 1246-1250, 1967.
8. Kaspersen, F. M., Bos, E., Doornmalen, A. V., Geerlings, M. W., Apostolidis, C., and Molinet, R. Cytotoxicity of 213Bi- and 225Ac-immunoconjugates. Nucl. Med. Commun., 16: 468-476, 1995.
9. Brechbiel, M. W., Gansow, O. A., Atcher, R. W., Schlom, J., Esteban, J., Simpson, D. E., and Colcher, D. Synthesis of 1-(p-isothiocya-natobenzyl) derivatives of DTPA and EDTA: antibody labeling and tumor imaging studies. Inorg. Chem., 25: 2772-2781, 1986.
10. Salacinski, P. R., McLean, C., Sykes, J. E., Clement, J. V., and Lowry, P. J. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal. Biochem., 117: 136-146, 1981.
11. Taswell, C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol, 126: 1614-1619, 1981.
12. Moreau, J. F., and Miller, R. G. Growth at limiting dilution of human T cell colonies from T cell- depleted peripheral blood leukocytes. J. Immunol, 130: 1139-1145, 1983.
13. Mossuz, P., Dobo, I., Genevay, M. C., Allegraud, A., Dautel, M., Niaussat, A. E., Cousin, F., Praloran, V., Boccaccio, C., and Hermouet, S. Use of collagen for standardization of PBSC graft quality evaluation: a multicenter comparative analysis of commercial collagen-based and methylcellulose-based colony-forming unit (CFU) assay kits. J. Hematother., 7: 351-359, 1998.
14. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. J. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods, 72: 77-89, 1984.
15. Raju, M. R., Eisen, Y., Carpenter, S., and Inkret, W. C. Radiobiology of alpha particles. III. Cell inactivation by alpha-particle traversals of the cell nucleus. Radiat. Res., 128: 204-209, 1991.
16. Barendsen, G. W. Dose-survival curves of human cells in tissue culture irradiated with alpha-, beta-, 20-KV.X- and, 200-KV.X-radiation. Nature. 193: 1153-1155, 1962.
17. 0) T-lymphocytes, T-lymphocyte lines, lymphoblastoid cell lines and fibroblasts from normal donors, from ataxia-telangiectasia patients and from ataxia-telangiectasia heterozygotes. Int. J. Radiat. Biol, 54: 929-943, 1988.
18. Szczylik, C., and Wiktor, J. W. The effects of x-irradiation in vitro on subpopulations of human lymphocytes. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 39: 253-263, 1981.
19. Kozak, R. W., Atcher, R. W., Gansow, O. A., Friedman, A. M., Hines, J. J., and Waldmann, T. A. Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle- emitting radionuclides as modalities for radioimmunotherapy. Proc. Natl. Acad. Sci. USA 83: 474-478, 1986.
20. Kotz, D. Alpha particle therapy poised to become new line of cancer treatment. J. Nucl. Med., 39: 17N-19N, 36N, 1998.
21. Wang, M. Y., Kvalheim, G., Kvaloy, S., Beiske, K., Jakobsen, E., Wijdenes, J., Pihl, A., and Fodstad, O. An effective immunomagnetic method for bone marrow purging in T cell malignancies. Bone Marrow Transplant., 9: 319-323, 1992.
22. Spyridonidis, A., Schmidt, M., Bernhardt, W., Papadimitriou, A., Azemar, M., Weis, W., Groner, B., and Henschler, R. Purging of mammary carcinoma cells during ex vivo culture of CD34+ hematopoietic progenitor cells with recombinant immunotoxins. Blood, 91: 1820-1827, 1998.
23. Bjorn, M. J., Manger, R., Sivam, G., Morgan, A. J., and Torok, S. B. Selective elimination of breast cancer cells from human bone marrow using an antibody-Pseudomonas exotoxin A conjugate. Cancer Res., 50: 5992-5996, 1990.
24. Ozaki, S., Kosaka, M., Wakatsuki, S., Abe, M., Koishihara, Y., and Matsumoto, T. Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM 1.24. Blood, 90: 3179-3186, 1997.